EQT to buy Swedish drug maker Recipharm: Bloomberg

EQT has agreed to acquire Recipharm, a Swedish pharmaceuticals company, reported Bloomberg.

EQT has agreed to acquire Recipharm, a Swedish pharmaceuticals company, reported Bloomberg. The purchase price is $2.1 billion.

Source: Bloomberg